167 related articles for article (PubMed ID: 32226525)
1. PET Imaging of Liposomal Glucocorticoids using
Gawne PJ; Clarke F; Turjeman K; Cope AP; Long NJ; Barenholz Y; Terry SYA; de Rosales RTM
Theranostics; 2020; 10(9):3867-3879. PubMed ID: 32226525
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoids in nano-liposomes administered intravenously and subcutaneously to adjuvant arthritis rats are superior to the free drugs in suppressing arthritis and inflammatory cytokines.
Ulmansky R; Turjeman K; Baru M; Katzavian G; Harel M; Sigal A; Naparstek Y; Barenholz Y
J Control Release; 2012 Jun; 160(2):299-305. PubMed ID: 22226777
[TBL] [Abstract][Full Text] [Related]
3. PET/CT Imaging of Human TNFα Using [
Beckford-Vera DR; Gonzalez-Junca A; Janneck JS; Huynh TL; Blecha JE; Seo Y; Li X; VanBrocklin HF; Franc BL
Mol Imaging Biol; 2020 Feb; 22(1):105-114. PubMed ID: 31065895
[TBL] [Abstract][Full Text] [Related]
4. [(18)]F FDG PET/CT imaging to monitor the therapeutic effect of liposome-encapsulated prednisolone in experimental rheumatoid arthritis.
van der Geest T; Metselaar JM; Gerrits D; van Lent PL; Storm G; Laverman P; Boerman OC
J Control Release; 2015 Jul; 209():20-6. PubMed ID: 25902038
[TBL] [Abstract][Full Text] [Related]
5. Nano-Drugs Based on Nano Sterically Stabilized Liposomes for the Treatment of Inflammatory Neurodegenerative Diseases.
Turjeman K; Bavli Y; Kizelsztein P; Schilt Y; Allon N; Katzir TB; Sasson E; Raviv U; Ovadia H; Barenholz Y
PLoS One; 2015; 10(7):e0130442. PubMed ID: 26147975
[TBL] [Abstract][Full Text] [Related]
6. B-cell imaging with zirconium-89 labelled rituximab PET-CT at baseline is associated with therapeutic response 24 weeks after initiation of rituximab treatment in rheumatoid arthritis patients.
Bruijnen S; Tsang-A-Sjoe M; Raterman H; Ramwadhdoebe T; Vugts D; van Dongen G; Huisman M; Hoekstra O; Tak PP; Voskuyl A; van der Laken C
Arthritis Res Ther; 2016 Nov; 18(1):266. PubMed ID: 27863504
[TBL] [Abstract][Full Text] [Related]
7. Immuno-PET and Immuno-SPECT of Rheumatoid Arthritis with Radiolabeled Anti-Fibroblast Activation Protein Antibody Correlates with Severity of Arthritis.
Laverman P; van der Geest T; Terry SY; Gerrits D; Walgreen B; Helsen MM; Nayak TK; Freimoser-Grundschober A; Waldhauer I; Hosse RJ; Moessner E; Umana P; Klein C; Oyen WJ; Koenders MI; Boerman OC
J Nucl Med; 2015 May; 56(5):778-83. PubMed ID: 25858044
[TBL] [Abstract][Full Text] [Related]
8. A kit formulation for the preparation of [
Man F; Khan AA; Carrascal-Miniño A; Blower PJ; T M de Rosales R
Nucl Med Biol; 2020; 90-91():31-40. PubMed ID: 32979725
[TBL] [Abstract][Full Text] [Related]
9. Manganese-52: applications in cell radiolabelling and liposomal nanomedicine PET imaging using oxine (8-hydroxyquinoline) as an ionophore.
Gawne P; Man F; Fonslet J; Radia R; Bordoloi J; Cleveland M; Jimenez-Royo P; Gabizon A; Blower PJ; Long N; de Rosales RTM
Dalton Trans; 2018 Jul; 47(28):9283-9293. PubMed ID: 29796500
[TBL] [Abstract][Full Text] [Related]
10. In Vivo PET Tracking of
Man F; Lim L; Volpe A; Gabizon A; Shmeeda H; Draper B; Parente-Pereira AC; Maher J; Blower PJ; Fruhwirth GO; T M de Rosales R
Mol Ther; 2019 Jan; 27(1):219-229. PubMed ID: 30429045
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoid-loaded pH/ROS dual-responsive nanoparticles alleviate joint destruction by downregulating the NF-κB signaling pathway.
Lu Y; Zhou J; Wang Q; Cai J; Yu B; Dai Q; Bao Y; Chen R; Zhang Z; Zhang D; Hou T
Acta Biomater; 2023 Jul; 164():458-473. PubMed ID: 37072065
[TBL] [Abstract][Full Text] [Related]
12. Simplified
Polyak A; Bankstahl JP; Besecke KFW; Hozsa C; Triebert W; Pannem RR; Manstein F; Borcholte T; Furch M; Zweigerdt R; Gieseler RK; Bengel FM; Ross TL
Pharmaceutics; 2021 Jul; 13(7):. PubMed ID: 34371788
[TBL] [Abstract][Full Text] [Related]
13. Exploiting the Metal-Chelating Properties of the Drug Cargo for In Vivo Positron Emission Tomography Imaging of Liposomal Nanomedicines.
Edmonds S; Volpe A; Shmeeda H; Parente-Pereira AC; Radia R; Baguña-Torres J; Szanda I; Severin GW; Livieratos L; Blower PJ; Maher J; Fruhwirth GO; Gabizon A; T M de Rosales R
ACS Nano; 2016 Nov; 10(11):10294-10307. PubMed ID: 27781436
[TBL] [Abstract][Full Text] [Related]
14. A generic
Li N; Yu Z; Pham TT; Blower PJ; Yan R
Int J Nanomedicine; 2017; 12():3281-3294. PubMed ID: 28458546
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of [(89)Zr]-Oxalate as a PET Tracer in Inflammation, Tumor, and Rheumatoid Arthritis Models.
Park JA; Lee YJ; Lee JW; Yoo RJ; Shin UC; Lee KC; Kim BI; Kim KM; Kim JY
Mol Pharm; 2016 Jul; 13(7):2571-7. PubMed ID: 27243098
[TBL] [Abstract][Full Text] [Related]
16. Companion Diagnostic
Lee H; Gaddy D; Ventura M; Bernards N; de Souza R; Kirpotin D; Wickham T; Fitzgerald J; Zheng J; Hendriks BS
Theranostics; 2018; 8(9):2300-2312. PubMed ID: 29721081
[TBL] [Abstract][Full Text] [Related]
17. Liposomal Treatment of Experimental Arthritis Can Be Monitored Noninvasively with a Radiolabeled Anti-Fibroblast Activation Protein Antibody.
van der Geest T; Laverman P; Gerrits D; Walgreen B; Helsen MM; Klein C; Nayak TK; Storm G; Metselaar JM; Koenders MI; Boerman OC
J Nucl Med; 2017 Jan; 58(1):151-155. PubMed ID: 27493266
[TBL] [Abstract][Full Text] [Related]
18. Preclinical evaluation and pilot clinical study of [
Ge L; Fu Z; Wei Y; Shi D; Geng Y; Fan H; Zhang R; Zhang Y; Li S; Wang S; Shi H; Song G; Pan J; Cheng K; Wang L
Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4025-4036. PubMed ID: 35715613
[TBL] [Abstract][Full Text] [Related]
19. Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes.
Metselaar JM; Wauben MH; Wagenaar-Hilbers JP; Boerman OC; Storm G
Arthritis Rheum; 2003 Jul; 48(7):2059-66. PubMed ID: 12847701
[TBL] [Abstract][Full Text] [Related]
20. Using PEGylated nano-liposomes to target tissue invaded by a foreign body.
Schroeder A; Sigal A; Turjeman K; Barenholz Y
J Drug Target; 2008 Aug; 16(7):591-5. PubMed ID: 18686129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
